Previous Close | 356.32 |
Open | 356.32 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 3,310.00 |
Expire Date | 2021-04-16 |
Day's Range | 356.32 - 356.32 |
Contract Range | N/A |
Volume | 3 |
Open Interest | N/A |
Amazon's (NASDAQ: AMZN) ad business might've been overshadowed in 2020 amid the boom in e-commerce that occurred as consumers stayed home and did more shopping online. Through the first nine months of 2020, Amazon's Other revenue line item, which consists primarily of advertising, increased 45%. Advertisers expect to spend larger and larger percentages of their ad budgets on Amazon ads over the next couple of years, according to a new survey from Cowen.
In this Motley Fool Live video recorded on Nov. 16, 2020, Bill Mann, director of small cap research for The Motley Fool, talks with Clover Health co-founder and CEO Vivek Garipalli about how his company wins over healthcare providers to use its platform. Bill Mann: Every single medical device company I've ever talked to, when they talk about the objections to getting broader adaptation, it hinges upon one thing.
2020 was a record year for initial public offerings (IPOs), with 480 companies going public on U.S. stock exchanges, and more stocks doubling in their first day of trading than ever before. 2021 is on track to be another huge year for IPOs, and some innovative companies making public market debuts could go on to deliver tremendous returns. With that in mind, we asked three Motley Fool contributors to profile a recent or upcoming IPO stock that looks primed to be a big winner.